Lipid rescue in children: The prompt decision

Related Experiment Video

Updated: Mar 19, 2026

Lipid Exchange Assay in Living Cells
08:59

Lipid Exchange Assay in Living Cells

Published on: March 21, 2025

1.3K

Ramón Eizaga Rebollar1, María V García Palacios2, Javier Morales Guerrero1

  • 1Department of Anesthesiology and Reanimation, Puerta del Mar University Hospital, Cádiz, Spain.

Journal of Clinical Anesthesia
|June 14, 2016
PubMed

Insights

A child experienced ECG changes after local anesthetic injection during surgery. Prompt treatment with Intralipid 30% successfully reversed these cardiac alterations, highlighting its effectiveness in pediatric cases.

Area of Science:

  • Anesthesiology
  • Pediatric Critical Care
  • Cardiology

Background:

  • Local anesthetics are widely used in pediatric surgery for pain management.
  • Complications from local anesthetic systemic toxicity (LAST) can be severe, particularly in children.
  • General anesthesia combined with caudal block is a common surgical approach for infants and young children.

Observation:

  • A 17-month-old child developed significant electrocardiogram (ECG) ST-T changes post-local anesthetic administration.
  • These ECG alterations indicated potential cardiac compromise following the procedure.
  • The patient received a caudal block as part of their general anesthesia for laparotomy.

Findings:

  • Intralipid 30% infusion was administered promptly upon detection of ECG abnormalities.
  • The intravenous lipid emulsion therapy successfully normalized the observed ST-T wave changes.
  • This case supports the efficacy of lipid rescue in pediatric patients experiencing local anesthetic toxicity.

Implications:

  • Early recognition and rapid intervention with lipid emulsion are crucial for managing severe LAST in pediatric patients.
  • This case underscores the importance of having lipid rescue protocols readily available in pediatric surgical settings.
  • Further research into pediatric-specific dosing and protocols for lipid rescue is warranted to optimize patient outcomes.

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.9K
Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit08:43

Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit

Published on: April 19, 2019

12.3K

Related Concept Videos

Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
What are Lipids?01:38

What are Lipids?

Overview
224.4K